Yang JJ

No ORCID on file · 7 papers in corpus · active 2012-2021

Study types

  • article 2
  • other 1

Condition tags

  • endometriosis 2
  • adenomyosis 1
other 2021
Molecular imaging and biology ·doi:10.1007/s11307-020-01565-x

PURPOSE: To evaluate the utility of three-dimensional (3D) amide proton transfer-weighted (APTw) imaging for differentiation of endometrial adenocarcinoma and uterine benign lesions. PROCEDURES: This prospective study enrolled 22 normal vo…

2020
BioMed research international ·doi:10.1155/2020/7272960

Bladder cancer (BLCA) is the most common urinary tract tumor and is the 11th most malignant cancer worldwide. With the development of in-depth multisystem sequencing, an increasing number of prognostic molecular markers have been identified…

2018
Journal of ovarian research ·doi:10.1186/s13048-018-0405-0

BackgroundSynchronous endometrial disorders have been poorly studied in women with endometrioid borderline ovarian tumors (EBOT). The aims of this study were to investigate the risk of endometrial disorders among women with EBOT and associa…

2018
BMC cancer ·doi:10.1186/s12885-018-5091-1

BackgroundBecause of the rarity of endometrioid borderline ovarian tumours (EBOTs), there is a paucity of data concerning the natural history and prognosis of this condition. Thus, the objective of our study was to establish the feasibility…

article 2017
Clinical and experimental obstetrics & gynecology ·doi:10.12891/ceog3148.2017

OBJECTIVE: To investigate the effects of the leflunomide (LEF) on the size of the transplanted endometriosis (EMS) lesions and trans- forming growth factor (TGF) -β1gray level in SD rats. MATERIALS AND METHODS: EMS was surgically induced in…

article 2016
Clinical and experimental obstetrics & gynecology ·doi:10.12891/ceog3053.2016

PURPOSE: To explore the function of Wnt/β-catenin signal pathway on promoting the adhesion, invasion, and metastasis of endometriosis tissues by analyzing its effects on the expressions of matrix metalloproteinase-7 (MMP-7) and vascular end…

2012
Frontiers in oncology ·doi:10.3389/fonc.2012.00194

Technological advances now allow us to rapidly produce CARs and other antibody-derived therapeutics targeting cell surface receptors. To maximize the potential of these new technologies, relevant extracellular targets must be identified. Th…